A Study to Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese Participants

Study Identifier
M24-227
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

Study Details

Medical Condition
  • Healthy Volunteer
  • Study Drug
  • ABBV-903
  • Placebo for ABBV-903
  • Phase
    Phase 1
    Sex
    Female & Male
    Age
    18 - 65 Years

    Protocol Summary

    The objective of this study is to assess the pharmacokinetics (PK), safety, and tolerability of ABBV-903 or placebo in healthy adult Japanese and Han Chinese subjects.

    Study Locations

    Location
    Status
    Location
    Anaheim Clinical Trials LLC /ID# 257033
    Anaheim, California, United States, 92801-2658
    Status
    Not applicable